All Stories

  1. Problems with ethics committee data for trials run in India
  2. Rare disease patients in India are rarely involved in international orphan drug trials
  3. Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data
  4. A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one
  5. Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law